On February 18, the journey of Cathie Wood Ark invest biotech stocks, began with buying shares of Recursion Pharmaceuticals and CRISPR Therapeutics.
Biotech
Unlearn.AI, which has built a machine learning platform that creates “digital twin” profiles of patients in clinical trials, has raised $15 million to expand partnerships and accelerate regulatory approval, the company told Reuters on Tuesday. The investment from Radical Ventures and Wittington Ventures valued the startup at $265 million, the company said. Mira Murati, chief […]